CAV1 and cancer: Primary outcome: To assess the feasibility of evaluating the effect of n-acetylcysteine on tumor cell metabolism by assessing the changes in expression of Cav-1 and MCT4 in cancer-associated fibroblasts in pre- and post-therapy breast tissue treated with NAC